Healthcare - Biotechnology - NASDAQ - US
$ 2.05
-4.65 %
$ 428 M
Market Cap
-1.68
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
14.17%
EBIT
Estimate
--0.25%
Net Income
Estimate
21.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sangamo Therapeutics, Inc.
SGMO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SGMO
EBIT FORECAST
EBIT Forecast Chart SGMO
NET INCOME FORECAST
Net Income Chart SGMO